Finance · Search · Sign in · Sign up

Lettie sells LGND 51.49: Ligand Pharmaceuticals (LGND) Posts Quarterly Earnings Results, Beats Estimates By $0.10 EPS


Ligand Pharmaceuticals (NASDAQ:LGND) posted its quarterly earnings results on Monday. The company reported $0.24 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.14 by $0.10, Stock Ratings Network.com reports. The company had ... ...


33 people liked this



See more

0 Comments:

Post a Comment

Subscribe to Post Comments [Atom]

<< Home